A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor

NCT04151329 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

BIOLOGICAL: BAT1306 and BAT8001 2.4mg/kg
BIOLOGICAL: BAT1306 and BAT8001 3.6mg/kg

Sponsor

Bio-Thera Solutions